Stock V3V VITA 34 AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings VITA 34 AG BOERSE MUENCHEN

Equities

V3V

DE000A0BL849

Market Closed - BOERSE MUENCHEN
Other stock markets
 15:44:13 2024-07-05 EDT 		5-day change 1st Jan Change
4.42 EUR -1.78% Intraday chart for VITA 34 AG -1.34% -15.97%
06-01 VITA 34 AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-30 VITA 34 AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • Sales forecast by analysts have been recently revised upwards.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
VITA 34 AG Stock VITA 34 AG
-15.97% 84.17M -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.33% 83.89B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.29% 71.08B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.99% 26.77B
C+
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.67% 17.74B
A-
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-9.99% 17.24B
B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+1.86% 15.6B
A-
NATERA, INC. Stock Natera, Inc.
+79.98% 13.84B
C-
PURE HEALTH HOLDING Stock Pure Health Holding
-25.09% 12.92B - -
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+74.41% 12.87B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. V3V Stock
  4. V3V Stock
  5. Ratings VITA 34 AG